Means Investment Company’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$603K Sell
7,273
-45,393
-86% -$3.76M 0.06% 116
2025
Q1
$4.27M Sell
52,666
-54,107
-51% -$4.39M 0.45% 35
2024
Q4
$9.62M Buy
106,773
+1,407
+1% +$127K 1% 18
2024
Q3
$10.4M Buy
105,366
+424
+0.4% +$41.9K 1.16% 18
2024
Q2
$9.73M Buy
104,942
+37,847
+56% +$3.51M 1.16% 16
2024
Q1
$6.37M Sell
67,095
-806
-1% -$76.5K 0.82% 24
2023
Q4
$6.06M Sell
67,901
-12,003
-15% -$1.07M 0.87% 22
2023
Q3
$5.83M Sell
79,904
-13,634
-15% -$996K 0.96% 19
2023
Q2
$7.78M Sell
93,538
-989
-1% -$82.3K 1.23% 19
2023
Q1
$7.2M Sell
94,527
-2,139
-2% -$163K 1.27% 17
2022
Q4
$8.02M Buy
96,666
+212
+0.2% +$17.6K 1.61% 13
2022
Q3
$7.65M Sell
96,454
-31
-0% -$2.46K 1.66% 12
2022
Q2
$7.17M Buy
96,485
+3,053
+3% +$227K 1.52% 12
2022
Q1
$8.4M Buy
93,432
+2,072
+2% +$186K 1.52% 12
2021
Q4
$10.2M Buy
91,360
+2,372
+3% +$266K 1.81% 11
2021
Q3
$11.2M Buy
88,988
+3,630
+4% +$456K 2.21% 11
2021
Q2
$11.6M Buy
85,358
+5,629
+7% +$762K 2.31% 9
2021
Q1
$10.8M Buy
79,729
+784
+1% +$106K 2.46% 7
2020
Q4
$13.1M Buy
78,945
+4,484
+6% +$744K 2.98% 5
2020
Q3
$8.93M Buy
74,461
+4,291
+6% +$514K 2.45% 6
2020
Q2
$7.68M Buy
70,170
+3,310
+5% +$362K 2.4% 6
2020
Q1
$6.27M Buy
66,860
+1,085
+2% +$102K 2.43% 6
2019
Q4
$6.33M Sell
65,775
-424
-0.6% -$40.8K 2.12% 10
2019
Q3
$5.5M Buy
66,199
+2,270
+4% +$189K 2.08% 9
2019
Q2
$5.56M Buy
63,929
+2,297
+4% +$200K 2.28% 9
2019
Q1
$5.58M Buy
61,632
+7,060
+13% +$639K 2.45% 6
2018
Q4
$3.92M Buy
+54,572
New +$3.92M 2.17% 7